Scinovex
article Open AccessTop 10% cited

Adjuvant Radiotherapy and 5-Fluorouracil After Curative Resection of Cancer of the Pancreas and Periampullary Region

Annals of Surgery · 1999 · Vol. 230(6) · pp. 776–776
Jean H. G. KlinkenbijlJohannes JeekelTarek SahmoudRenée van PelM.L. CouvreurC.H.N. VeenhofJean ArnaudDionisio GonzálezL T de WitA. HennipmanJ. Wils

Abstract

Adjuvant radiotherapy in combination with 5-fluorouracil is safe and well tolerated. However, the benefit in this study was small; routine use of adjuvant chemoradiotherapy is not warranted as standard treatment in cancer of the head of the pancreas or periampullary region.

Pancreatic and Hepatic Oncology ResearchCholangiocarcinoma and Gallbladder Cancer StudiesGastric Cancer Management and OutcomesMedicinePeriampullary cancerPancreatic cancerRadiation therapyAdenocarcinomaGastroenterologyInternal medicineFluorouracilAdjuvantSurgery

MeSH terms

AdenocarcinomaAdultAgedAged, 80 and overAntimetabolites, AntineoplasticFluorouracilHumansMiddle AgedPancreatic NeoplasmsProspective StudiesAmpulla of VaterSurvival AnalysisChemotherapy, AdjuvantRadiotherapy, Adjuvant
Citations
1,260
FWCI
10.30
field-weighted impact
References
39
Percentile
99%
vs. same field & year
Citations per year
Citation Network

How this paper connects to the literature. Drag to explore, click any node to open that paper.

Adjuvant Radiotherapy and 5-Fluorouracil After Curative Resection of Cancer of the Pancreas and Periampullary Region · Scinovex